Abstract | BACKGROUND: Previous research supports a role for soy protein in reducing serum lipids; however, few studies involved healthy male subjects or focused on soy isoflavones (or did both). OBJECTIVE: DESIGN: RESULTS: Urinary isoflavones were significantly greater with consumption of the high-iso SPI than with that of the low-iso SPI or MPI. The differences between the 3 treatments with respect to individual serum lipids were not significant, but the ratios of total to HDL cholesterol, LDL to HDL cholesterol, and apo B to apo A-I were significantly lower with both SPI treatments than with MPI treatment. CONCLUSION:
|
Authors | Brianne L McVeigh, Barbara L Dillingham, Johanna W Lampe, Alison M Duncan |
Journal | The American journal of clinical nutrition
(Am J Clin Nutr)
Vol. 83
Issue 2
Pg. 244-51
(Feb 2006)
ISSN: 0002-9165 [Print] United States |
PMID | 16469981
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Apolipoprotein A-I
- Apolipoproteins B
- Cholesterol, HDL
- Cholesterol, LDL
- Isoflavones
- Lipids
- Soybean Proteins
- Triglycerides
- C-Reactive Protein
- Cholesterol
|
Topics |
- Adult
- Apolipoprotein A-I
(blood)
- Apolipoproteins B
(blood)
- C-Reactive Protein
(metabolism)
- Cardiovascular Diseases
(blood, prevention & control)
- Cholesterol
(blood)
- Cholesterol, HDL
(blood)
- Cholesterol, LDL
(blood)
- Cross-Over Studies
- Dose-Response Relationship, Drug
- Humans
- Isoflavones
(administration & dosage, blood, urine)
- Lipids
(blood, chemistry)
- Male
- Risk Factors
- Soybean Proteins
(administration & dosage, chemistry)
- Triglycerides
(blood)
|